Changing Paradigms in Comprehensive Pain Management: Update on Abuse-Deterrent Opioids

Description

Opioids play an important role in the management of moderate-to-severe pain and the use of opioid medications has steadily increased over the past few decades. With the growing use of opioids, there has been a correlating increase in opioid abuse, diversion, and misuse. To combat opioid abuse, a multifaceted approach is needed that can include the use of abuse-deterrent formulations (ADFs). ADFs can employ various technologies, such as physical/chemical barriers to prevent crushing or extraction, as well as the use of an agonist/antagonist combination that neutralizes the opioid effect if manipulated. Though the use of ADFs can be an important component in ensuring the responsible use of opioids, the incorporation of ADFs into pain management decisions will require a thorough understanding of the available formulations, including the technologies utilized, dosing for optimal effectiveness, and safety considerations. This program will review the burden of opioid abuse in today’s society while providing an overview of the current and emerging ADF technologies. This program will also highlight the role of pharmacists in guiding pain management decisions as part of an interprofessional healthcare team.

Speaker: Gregory Holmquist, PharmD, LTC Elderly Pain Consultant

Register today at http://www.vemcomeded.com/livemeetings.asp

 

Pharmacist Learning Objectives

Learners participating in the program will be able at its conclusion to:

  1. Identify the role of pharmacists in reducing risk of opioid use through a multifaceted approach that includes interprofessional communication, patient education, and pharmaceutical selection.  
  2. Describe abuse-deterrent technologies utilized in current and emerging opioid medications aimed at reducing patient risk.
  3. Evaluate the role of abuse-deterrent opioids as part of comprehensive pain management plans for patients with chronic pain.

.

 
 

Supporter

Center for Independent Healthcare Education and Vemco MedEd and supported by Daiichi Sankyo, Inc.

 
Learning Level: Level 1
Track: Satellite Symposia
Session Time Slot(s): 
Date: 
Saturday, March 23
Time: 
6:00 AM - 8:00 AM
Room: 
Grand Hyatt Seattle - Leonesa I
ACPE Pharmacist: 0473-9999-19-002-L01-P
CEUs Pharmacist: .15
Activity Type:
Application-based